| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fulcrum Therapeutics, Inc. (FULC) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. FULC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.85M | $33.37M | - | |
| Dir | 469.9K | $1.77M | - | |
| Dir | 36.0K | $135.7K | - | |
| Dir | 36.0K | $135.7K | - | |
| Dir | 36.0K | $135.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2020 | Gould Robert J85 | See Remarks | Sell | 2,800 | $20.09 | $56,250.43 | -0.3% | |
| Jun 3, 2020 | Cadavid Diego | SVP Clinical Development | Sale+OE | 383 | $20.16 | $7,719.59 | -0.3% | |
| Jun 2, 2020 | Gould Robert J85 | See Remarks | Sell | 2,802 | $20.00 | $56,040.00 | -0.3% | |
| May 29, 2020 | Cadavid Diego | SVP Clinical Development | Sale+OE | 800 | $20.01 | $16,007.00 | -0.6% | |
| May 29, 2020 | Gould Robert J85 | See Remarks | Sell | 3,309 | $20.04 | $66,301.91 | -0.3% | |
| May 28, 2020 | Wallace Owen B. | Chief Scientific Officer | Sale+OE | 2,232 | $20.00 | $44,640.00 | -1.7% | |
| May 27, 2020 | Wallace Owen B. | Chief Scientific Officer | Sale+OE | 448 | $20.00 | $8,960.00 | -0.4% | |
| May 26, 2020 | Wallace Owen B. | Chief Scientific Officer | Sale+OE | 412 | $20.00 | $8,240.00 | -0.3% | |
| May 26, 2020 | Gould Robert J85 | See Remarks | Sell | 2,500 | $20.00 | $50,000.00 | -0.5% | |
| May 12, 2020 | Cadavid Diego | SVP Clinical Development | Sale+OE | 1,860 | $18.00 | $33,480.00 | -2.7% |